South Africa · Delayed Price · Currency is ZAR · Price in ZAc Aspen Pharmacare Holdings Statistics
Total Valuation
JSE:APN has a market cap or net worth of ZAR 68.49 billion. The enterprise value is 95.81 billion.
| Market Cap | 68.49B |
| Enterprise Value | 95.81B |
Important Dates
The next confirmed earnings date is Wednesday, September 2, 2026.
| Earnings Date | Sep 2, 2026 |
| Ex-Dividend Date | Oct 1, 2025 |
Share Statistics
JSE:APN has 444.02 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 444.02M |
| Shares Outstanding | 444.02M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 17.55% |
| Owned by Institutions (%) | 58.71% |
| Float | 366.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 17.06 |
| PS Ratio | 1.61 |
| PB Ratio | 0.84 |
| P/TBV Ratio | 2.03 |
| P/FCF Ratio | 15.48 |
| P/OCF Ratio | 9.88 |
| PEG Ratio | 1.57 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.22, with an EV/FCF ratio of 21.66.
| EV / Earnings | n/a |
| EV / Sales | 2.25 |
| EV / EBITDA | 12.22 |
| EV / EBIT | 15.86 |
| EV / FCF | 21.66 |
Financial Position
The company has a current ratio of 3.64, with a Debt / Equity ratio of 0.41.
| Current Ratio | 3.64 |
| Quick Ratio | 1.03 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 4.20 |
| Debt / FCF | 7.45 |
| Interest Coverage | 3.29 |
Financial Efficiency
Return on equity (ROE) is -2.17% and return on invested capital (ROIC) is 5.57%.
| Return on Equity (ROE) | -2.17% |
| Return on Assets (ROA) | 2.85% |
| Return on Invested Capital (ROIC) | 5.57% |
| Return on Capital Employed (ROCE) | 5.38% |
| Weighted Average Cost of Capital (WACC) | 5.58% |
| Revenue Per Employee | 4.56M |
| Profits Per Employee | -213,957 |
| Employee Count | 9,557 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 1.41 |
Taxes
In the past 12 months, JSE:APN has paid 696.00 million in taxes.
| Income Tax | 696.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.69% in the last 52 weeks. The beta is 0.35, so JSE:APN's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +30.69% |
| 50-Day Moving Average | 14,042.30 |
| 200-Day Moving Average | 11,726.46 |
| Relative Strength Index (RSI) | 72.08 |
| Average Volume (20 Days) | 870,725 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, JSE:APN had revenue of ZAR 42.59 billion and -2.00 billion in losses. Loss per share was -4.50.
| Revenue | 42.59B |
| Gross Profit | 18.31B |
| Operating Income | 6.04B |
| Pretax Income | -1.11B |
| Net Income | -2.00B |
| EBITDA | 7.61B |
| EBIT | 6.04B |
| Loss Per Share | -4.50 |
Balance Sheet
The company has 5.62 billion in cash and 32.94 billion in debt, with a net cash position of -27.32 billion or -61.54 per share.
| Cash & Cash Equivalents | 5.62B |
| Total Debt | 32.94B |
| Net Cash | -27.32B |
| Net Cash Per Share | -61.54 |
| Equity (Book Value) | 81.09B |
| Book Value Per Share | 182.38 |
| Working Capital | 41.56B |
Cash Flow
In the last 12 months, operating cash flow was 6.93 billion and capital expenditures -2.51 billion, giving a free cash flow of 4.42 billion.
| Operating Cash Flow | 6.93B |
| Capital Expenditures | -2.51B |
| Depreciation & Amortization | 1.57B |
| Net Borrowing | -1.55B |
| Free Cash Flow | 4.42B |
| FCF Per Share | 9.96 |
Margins
Gross margin is 42.99%, with operating and profit margins of 14.19% and -4.69%.
| Gross Margin | 42.99% |
| Operating Margin | 14.19% |
| Pretax Margin | -2.61% |
| Profit Margin | -4.69% |
| EBITDA Margin | 17.86% |
| EBIT Margin | 14.19% |
| FCF Margin | 10.39% |
Dividends & Yields
This stock pays an annual dividend of 2.11, which amounts to a dividend yield of 1.37%.
| Dividend Per Share | 2.11 |
| Dividend Yield | 1.37% |
| Dividend Growth (YoY) | -41.23% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | 1.39% |
| Earnings Yield | -2.92% |
| FCF Yield | 6.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for JSE:APN is 15,050.00, which is -2.43% lower than the current price. The consensus rating is "Buy".
| Price Target | 15,050.00 |
| Price Target Difference | -2.43% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | -1.84% |
| EPS Growth Forecast (3Y) | 9.12% |
Stock Splits
The last stock split was on October 6, 2008. It was a forward split with a ratio of 1.0175.
| Last Split Date | Oct 6, 2008 |
| Split Type | Forward |
| Split Ratio | 1.0175 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |